Gaps in treatment amongst metastatic castration resistant prostate cancer (mCRPC) patients taking abiraterone acetate or enzalutamide.

被引：0
|
作者：
Behl, Ajay
Ellis, Lorie
Pilon, Dominic
Xiao, Yongling
Lefebvre, Patrick
Dawson, Nancy Ann
机构：
[1] Janssen Sci Affairs LLC, Horsham, PA USA
[2] 1000 Gauchetiere Ouest, Montreal, PQ, Canada
[3] Grp Anal Ltee, Montreal, PQ, Canada
[4] Lombardi Comprehens Canc Ctr, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 02期
关键词：
D O I：
10.1200/jco.2016.34.2_suppl.334
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
334
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Overall survival by race in chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate or enzalutamide.
    McNamara, Megan Ann
    George, Daniel J.
    Ramaswamy, Krishnan
    Lechpammer, Stanislav
    Mardekian, Jack
    Schultz, Neil M.
    Wang, Li
    Baser, Onur
    Huang, Ahong
    Freedland, Stephen J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [2] Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate or enzalutamide.
    Buonerba, Carlo
    Sonpavde, Guru
    Pond, Gregory Russell
    Pagliuca, Martina
    Rossetti, Sabrina
    Facchini, Gaetano
    Scagliarini, Sarah
    Daniele, Bruno
    Federico, Piera
    Morelli, Franco
    Carteni, Giacomo
    Ferro, Matteo
    Lucarelli, Giuseppe
    Bellelli, Teresa
    De Placido, Sabino
    di Lorenzo, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Enzalutamide (ENZA) in combination with abiraterone acetate (AA) in bone metastatic castration resistant prostate cancer (mCRPC)
    Efstathiou, Eleni
    Titus, Mark Anton
    Wen, Sijin
    SanMiguel, Aileen
    Hoang, Anh
    De Haas-Amatsaleh, Angela
    Perabo, Frank
    De Phung
    Troncoso, Patricia
    Ouatas, Taoufik
    Logothetis, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] The effects of enzalutamide (ENZA) in combination with abiraterone acetate (AA) in patients with bone metastatic castration resistant prostate cancer (mCRPC)
    Efstathiou, E.
    Titus, M.
    Wen, A. S.
    San Miguel, A.
    Hoang, A.
    De Haas-Amatsaleh, A.
    Perabo, F.
    Phung, D.
    Troncoso, P.
    Logothetis, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S680 - S681
  • [5] Cost per median overall survival month for abiraterone acetate and enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer (mCRPC).
    Pilon, Dominic
    Lefebvre, Patrick
    Queener, Marykay
    Ellis, Lorie
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] CARD: Overall survival (OS) analysis of patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel versus abiraterone or enzalutamide.
    Tombal, Bertrand F.
    Castellano, Daniel
    Kramer, Gero
    Eymard, Jean-Christophe
    De Bono, Johann S.
    Sternberg, Cora N.
    Fizazi, Karim
    Wulfing, Christian
    Bamias, Aristotelis
    Carles, Joan
    Iacovelli, Roberto
    Melichar, Bohuslav
    Sverrisdottir, Asgerdur
    Theodore, Christine
    Feyerabend, Susan
    Helissey, Carole
    Poole, Elizabeth
    Ozatilgan, Ayse
    Geffriaud-Ricouard, Christine
    De Wit, Ronald
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Frailty and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
    Deol, Ekamjit Singh
    Luo, Suhong
    Sanfilippo, Kristen Marie
    Eisen, Seth A.
    Schoen, Martin W.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [8] Enzalutamide versus abiraterone acetate for the treatment of men with metastatic castration-resistant prostate cancer
    Zhang, Tian
    Zhu, Jason
    George, Daniel J.
    Armstrong, Andrew J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (04) : 473 - 485
  • [9] CARDIOVASCULAR RISK IN CASTRATION RESISTANT PROSTATE CANCER PATIENTS TREATED WITH ABIRATERONE ACETATE OR ENZALUTAMIDE. A META-ANALYSIS
    Alesini, Daniele
    Iacovelli, Roberto
    Palleschi, Michela
    Pochesci, Alessia
    Modica, Daniela
    Attili, Ilaria
    Piesco, Gabriele
    Scagnoli, Simone
    Orlando, Valentina
    Cortesi, Enrico
    ANTICANCER RESEARCH, 2013, 33 (05) : 2340 - 2340
  • [10] Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients
    Efstathiou, Eleni
    Titus, Mark
    Wen, Sijin
    Troncoso, Patricia
    Hoang, Anh
    Corn, Paul
    Prokhorova, Ina
    Araujo, John
    Dmuchowski, Carl
    Melhem-Bertrandt, Amal
    Patil, Shiva
    Logothetis, Christopher J.
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (01): : 119 - 127
12345